H2AX and Bloom syndrome: Despite lower initial H2AX phosphorylation and severely delayed dephosphorylation compared to wildtype cells, blm‐P868L cells responded significantly better to repeated CPT exposure than Bloom syndrome cells (Fig. 3 and 4C).